核医学放射性同位素市场：依产品类型（诊断、治疗）、用途（胃肠、神经、肿瘤）、最终用户 - 全球预测 2023-2030

预计2023年全球核医学放射性同位素市场将大幅成长，达104.6578亿美元，复合年增长率为14.43%，2030年将达270.0559亿美元。

FPNV定位矩阵

FPNV定位矩阵对于评估全球核医学放射性同位素市场至关重要。透过检查业务策略和产品满意度的关键指标，我们对供应商进行全面评估，使您能够根据您的特定需求做出明智的资讯。这种进阶分析将供应商分为四个像限，并取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市占率分析

市场占有率分析可以深入了解供应商在特定市场领域的当前地位。比较供应商对总收入、基本客群和其他关键指标的贡献，可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。该分析还揭示了特定行业的竞争程度、累积和合併的优势以及研究基准年的合併特征。

本报告提供了以下几点见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开发：提供有关利润丰厚的新兴市场的详细资讯，并分析其在成熟市场的渗透率。

3. 市场多元化：提供有关新产品发布、未开发地区、最新发展和投资的详细资讯。

4.市场趋势：全面了解COVID-19、俄罗斯-乌克兰衝突和高通膨的累积影响。

5.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、法规状况、专利状况、製造能力等进行综合评估。

6. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告回答了以下问题：

1. 核子医学放射性同位素的全球市场规模与预测为何？

2.在预测期内，COVID-19 影响全球核医学放射性同位素市场的阻碍因素与影响有哪些？

3. 在预测期内，全球核医学放射性同位素市场需要投资哪些产品/细分市场/用途/领域？

4.全球核医学放射性同位素市场的竞争策略是什么？

5. 全球核子医学放射性同位素市场的技术趋势和法律规范是什么？

6.全球核医学放射性同位素市场主要供应商的市占率是多少？

7. 哪些型态和策略措施被认为适合进入核医学放射性同位素全球市场？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

• 市场动态
  • 促进因素
    • 对 SPECT、PET 扫描和核子医学的需求不断增长
    • 放射性药物显着成长
    • 癌症和心臟病的罹患率增加
  • 抑制因素
    • 较高的暴露特异性副作用
  • 机会
    • 放射治疗显着增加
    • 治疗诊断学在核子医学中日益普及
  • 任务
    • 严格的政府法规
• 市场趋势
• COVID-19 的累积影响
• 俄罗斯-乌克兰衝突的累积影响
• 高通膨的累积效应
• 波特五力分析
• 价值炼和关键路径分析
• 法律规范
• 客户客製化

第6章医学放射性同位素市场：依产品类型

• 介绍
• 诊断
  • 氟18
  • 镓67
  • 鎝99
  • 铊201
• 治疗
  • 碘131
  • 铼186
  • 钐153
  • 钇90

第7章医学放射性同位素市场：依用途

• 介绍
• 消化器官
• 神经
• 瘤
• 整形外科

第8章医学放射性同位素市场：依最终使用者分类

• 介绍
• 诊断中心
• 教育及研究机构
• 医院
• 专科诊所

第9章美洲核医学放射性同位素市场

• 介绍
• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美国

第10章亚太核医学放射性同位素市场

• 介绍
• 澳洲
• 中国
• 印度
• 印尼
• 日本
• 马来西亚
• 菲律宾
• 新加坡
• 韩国
• 台湾
• 泰国
• 越南

第11章欧洲、中东及非洲核子医学放射性同位素市场

• 介绍
• 丹麦
• 埃及
• 芬兰
• 法国
• 德国
• 以色列
• 义大利
• 荷兰
• 奈及利亚
• 挪威
• 波兰
• 卡达
• 俄罗斯
• 沙乌地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公国
• 英国

第12章竞争形势

• FPNV定位矩阵
• 市占率分析：主要企业
• 竞争情境分析：主要企业

第13章上市公司名单

第14章附录

• 讨论指南
• 关于许可证和定价

The Global Nuclear Medicine Radioisotopes Market is forecasted to grow significantly, with a projected USD 10,465.78 million in 2023 at a CAGR of 14.43% and expected to reach a staggering USD 27,005.59 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Nuclear Medicine Radioisotopes Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Nuclear Medicine Radioisotopes Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product Type, market is studied across Diagnostics and Therapeutic. The Diagnostics is further studied across Fluorine-18, Gallium-67, Technetium-99, and Thallium-201. The Therapeutic is further studied across Iodine-131, Rhenium-186, Samarium-153, and Yttrium-90. The Therapeutic is projected to witness significant market share during forecast period.

Based on Application, market is studied across Gastroenterology, Neurology, Oncology, and Orthopedics. The Orthopedics is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Diagnostic Centers, Education & Research Institutes, Hospitals, and Specialty Clinics. The Hospitals is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Nuclear Medicine Radioisotopes Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Nuclear Medicine Radioisotopes Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Nuclear Medicine Radioisotopes Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Nuclear Medicine Radioisotopes Market?

4. What is the competitive strategic window for opportunities in the Global Nuclear Medicine Radioisotopes Market?

5. What are the technology trends and regulatory frameworks in the Global Nuclear Medicine Radioisotopes Market?

6. What is the market share of the leading vendors in the Global Nuclear Medicine Radioisotopes Market?

7. What modes and strategic moves are considered suitable for entering the Global Nuclear Medicine Radioisotopes Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Nuclear Medicine Radioisotopes Market, by Product Type, 2022 vs 2030
• 4.3. Nuclear Medicine Radioisotopes Market, by Application, 2022 vs 2030
• 4.4. Nuclear Medicine Radioisotopes Market, by End-User, 2022 vs 2030
• 4.5. Nuclear Medicine Radioisotopes Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing need for SPECT, PET scan and nuclear medicine
    • 5.1.1.2. Remarkable growth of radiopharmaceutical drugs
    • 5.1.1.3. Increasing prevalence of cancer and cardiac disorders
  • 5.1.2. Restraints
    • 5.1.2.1. Side effects with higher exposure
  • 5.1.3. Opportunities
    • 5.1.3.1. Substantial growth of radiation therapy
    • 5.1.3.2. Emerging popularity of theranostics in nuclear medicine
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent government regulations
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Nuclear Medicine Radioisotopes Market, by Product Type

• 6.1. Introduction
• 6.2. Diagnostics
  • 6.2.1. Fluorine-18
  • 6.2.2. Gallium-67
  • 6.2.3. Technetium-99
  • 6.2.4. Thallium-201
• 6.3. Therapeutic
  • 6.3.1. Iodine-131
  • 6.3.2. Rhenium-186
  • 6.3.3. Samarium-153
  • 6.3.4. Yttrium-90

7. Nuclear Medicine Radioisotopes Market, by Application

• 7.1. Introduction
• 7.2. Gastroenterology
• 7.3. Neurology
• 7.4. Oncology
• 7.5. Orthopedics

8. Nuclear Medicine Radioisotopes Market, by End-User

• 8.1. Introduction
• 8.2. Diagnostic Centers
• 8.3. Education & Research Institutes
• 8.4. Hospitals
• 8.5. Specialty Clinics

9. Americas Nuclear Medicine Radioisotopes Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Nuclear Medicine Radioisotopes Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Nuclear Medicine Radioisotopes Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. FPNV Positioning Matrix
• 12.2. Market Share Analysis, By Key Player
• 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

• 14.1. Discussion Guide
• 14.2. License & Pricing

LIST OF FIGURES

• FIGURE 1. NUCLEAR MEDICINE RADIOISOTOPES MARKET RESEARCH PROCESS
• FIGURE 2. NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, 2022 VS 2030
• FIGURE 3. NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2022 VS 2030 (%)
• FIGURE 5. NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
• FIGURE 6. NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
• FIGURE 7. NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 8. NUCLEAR MEDICINE RADIOISOTOPES MARKET DYNAMICS
• FIGURE 9. NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 10. NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. UNITED STATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. NUCLEAR MEDICINE RADIOISOTOPES MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 17. NUCLEAR MEDICINE RADIOISOTOPES MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. NUCLEAR MEDICINE RADIOISOTOPES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 5. NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 6. NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY FLUORINE-18, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY GALLIUM-67, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY TECHNETIUM-99, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THALLIUM-201, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 12. NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY IODINE-131, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY RHENIUM-186, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY SAMARIUM-153, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY YTTRIUM-90, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 18. NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 23. NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY EDUCATION & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 43. CANADA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 44. CANADA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 45. CANADA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 46. CANADA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. CANADA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. ASIA-PACIFIC NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. AUSTRALIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 68. AUSTRALIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. AUSTRALIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. CHINA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 71. CHINA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 72. CHINA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 73. CHINA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. CHINA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 75. INDIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 76. INDIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 77. INDIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 78. INDIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. INDIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. INDONESIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 83. INDONESIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. INDONESIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 85. JAPAN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 86. JAPAN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 88. JAPAN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. JAPAN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. MALAYSIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 91. MALAYSIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 93. MALAYSIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. MALAYSIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 95. PHILIPPINES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 96. PHILIPPINES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 98. PHILIPPINES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. PHILIPPINES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. SINGAPORE NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 103. SINGAPORE NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. SINGAPORE NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 105. SOUTH KOREA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 108. SOUTH KOREA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. SOUTH KOREA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 110. TAIWAN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 113. TAIWAN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. TAIWAN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 115. THAILAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 118. THAILAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. THAILAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 120. VIETNAM NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 121. VIETNAM NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 123. VIETNAM NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. VIETNAM NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 125. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 131. DENMARK NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 132. DENMARK NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 134. DENMARK NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. DENMARK NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 136. EGYPT NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 137. EGYPT NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 139. EGYPT NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. EGYPT NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 141. FINLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 142. FINLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 144. FINLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 145. FINLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 146. FRANCE NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 147. FRANCE NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 149. FRANCE NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 150. FRANCE NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 151. GERMANY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 152. GERMANY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 154. GERMANY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 155. GERMANY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 156. ISRAEL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 157. ISRAEL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 159. ISRAEL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 160. ISRAEL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 161. ITALY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 162. ITALY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 163. ITALY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 164. ITALY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 165. ITALY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 166. NETHERLANDS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 167. NETHERLANDS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 169. NETHERLANDS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 170. NETHERLANDS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 171. NIGERIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 172. NIGERIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 174. NIGERIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 175. NIGERIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 176. NORWAY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 177. NORWAY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 179. NORWAY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 180. NORWAY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 181. POLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 182. POLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 183. POLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 184. POLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 185. POLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 186. QATAR NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 187. QATAR NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 188. QATAR NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 189. QATAR NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 190. QATAR NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 191. RUSSIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 192. RUSSIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 194. RUSSIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 195. RUSSIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 196. SAUDI ARABIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 197. SAUDI ARABIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 199. SAUDI ARABIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 200. SAUDI ARABIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 201. SOUTH AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 205. SOUTH AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 206. SPAIN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 207. SPAIN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 209. SPAIN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 210. SPAIN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 211. SWEDEN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 212. SWEDEN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 214. SWEDEN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 215. SWEDEN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 216. SWITZERLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 217. SWITZERLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 219. SWITZERLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 220. SWITZERLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 221. TURKEY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 222. TURKEY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 224. TURKEY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 225. TURKEY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 226. UNITED ARAB EMIRATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 227. UNITED ARAB EMIRATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 229. UNITED ARAB EMIRATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 230. UNITED ARAB EMIRATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 231. UNITED KINGDOM NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 232. UNITED KINGDOM NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
• TABLE 234. UNITED KINGDOM NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 235. UNITED KINGDOM NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 236. NUCLEAR MEDICINE RADIOISOTOPES MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 237. NUCLEAR MEDICINE RADIOISOTOPES MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 238. NUCLEAR MEDICINE RADIOISOTOPES MARKET LICENSE & PRICING